Bifogade filer
Kurs & Likviditet
Kalender
2025-02-02 | Bokslutskommuniké 2024 |
2024-11-07 | Kvartalsrapport 2024-Q3 |
2024-08-26 | Kvartalsrapport 2024-Q2 |
2024-05-15 | Halvårsutdelning CONTX 0.15026 |
2024-05-14 | Årsstämma 2024 |
2024-05-08 | Kvartalsrapport 2024-Q1 |
2024-02-15 | Bokslutskommuniké 2023 |
2023-11-02 | Halvårsutdelning CONTX 0.15741 |
2023-10-26 | Kvartalsrapport 2023-Q3 |
2023-08-24 | Kvartalsrapport 2023-Q2 |
2023-05-08 | Halvårsutdelning CONTX 0.15741 |
2023-05-03 | Årsstämma 2023 |
2023-04-27 | Kvartalsrapport 2023-Q1 |
2023-02-16 | Bokslutskommuniké 2022 |
2022-10-20 | Kvartalsrapport 2022-Q3 |
2022-08-11 | Kvartalsrapport 2022-Q2 |
2022-05-05 | Ordinarie utdelning CONTX 0.00 NOK |
2022-05-04 | Årsstämma 2022 |
2022-04-21 | Kvartalsrapport 2022-Q1 |
2022-02-17 | Bokslutskommuniké 2021 |
2021-12-10 | Extra Bolagsstämma 2021 |
2021-10-21 | Kvartalsrapport 2021-Q3 |
2021-08-12 | Kvartalsrapport 2021-Q2 |
2021-05-06 | Ordinarie utdelning CONTX 0.00 NOK |
2021-05-05 | Årsstämma 2021 |
2021-04-22 | Kvartalsrapport 2021-Q1 |
2021-02-18 | Bokslutskommuniké 2020 |
2020-10-22 | Kvartalsrapport 2020-Q3 |
2020-08-19 | Split CONTX 1:10 |
2020-08-13 | Kvartalsrapport 2020-Q2 |
2020-08-05 | Extra Bolagsstämma 2020 |
2020-05-07 | Ordinarie utdelning CONTX 0.00 NOK |
2020-05-06 | Årsstämma 2020 |
2020-04-23 | Kvartalsrapport 2020-Q1 |
2020-02-20 | Bokslutskommuniké 2019 |
2019-10-24 | Kvartalsrapport 2019-Q3 |
2019-08-15 | Kvartalsrapport 2019-Q2 |
2019-05-09 | Ordinarie utdelning CONTX 0.00 NOK |
2019-05-08 | Årsstämma 2019 |
2019-04-25 | Kvartalsrapport 2019-Q1 |
2019-02-21 | Bokslutskommuniké 2018 |
2018-10-25 | Kvartalsrapport 2018-Q3 |
2018-08-16 | Kvartalsrapport 2018-Q2 |
2018-05-11 | Ordinarie utdelning CONTX 0.00 NOK |
2018-05-09 | Årsstämma 2018 |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-02-22 | Bokslutskommuniké 2017 |
2017-10-26 | Kvartalsrapport 2017-Q3 |
2017-08-17 | Kvartalsrapport 2017-Q2 |
2017-05-11 | Ordinarie utdelning CONTX 0.00 NOK |
2017-05-10 | Årsstämma 2017 |
2017-04-27 | Kvartalsrapport 2017-Q1 |
2017-02-23 | Bokslutskommuniké 2016 |
2016-10-27 | Kvartalsrapport 2016-Q3 |
2016-08-18 | Kvartalsrapport 2016-Q2 |
2016-04-21 | Kvartalsrapport 2016-Q1 |
2016-04-21 | Ordinarie utdelning CONTX 0.00 NOK |
2016-04-20 | Årsstämma 2016 |
2016-02-18 | Bokslutskommuniké 2015 |
2015-10-22 | Kvartalsrapport 2015-Q3 |
2015-08-20 | Kvartalsrapport 2015-Q2 |
2015-04-23 | Ordinarie utdelning CONTX 0.00 NOK |
2015-04-23 | Kvartalsrapport 2015-Q1 |
2015-04-22 | Årsstämma 2015 |
2015-02-19 | Bokslutskommuniké 2014 |
2014-10-23 | Kvartalsrapport 2014-Q3 |
2014-08-21 | Kvartalsrapport 2014-Q2 |
2014-05-12 | 15-7 2014 |
2014-04-24 | Ordinarie utdelning CONTX 0.00 NOK |
2014-04-24 | Kvartalsrapport 2014-Q1 |
2014-04-23 | Årsstämma 2014 |
2014-02-20 | Bokslutskommuniké 2013 |
2013-10-24 | Kvartalsrapport 2013-Q3 |
2013-08-22 | Kvartalsrapport 2013-Q2 |
2013-06-13 | Ordinarie utdelning CONTX 0.00 NOK |
2013-06-12 | Årsstämma 2013 |
2013-04-25 | Kvartalsrapport 2013-Q1 |
2013-02-21 | Bokslutskommuniké 2012 |
2012-10-25 | Kvartalsrapport 2012-Q3 |
2012-08-23 | Kvartalsrapport 2012-Q2 |
2012-06-14 | Ordinarie utdelning CONTX 0.00 NOK |
2012-06-13 | Årsstämma 2012 |
2012-04-26 | Kvartalsrapport 2012-Q1 |
2012-02-23 | Bokslutskommuniké 2011 |
2011-10-27 | Kvartalsrapport 2011-Q3 |
2011-08-25 | Kvartalsrapport 2011-Q2 |
2011-06-10 | Ordinarie utdelning CONTX 0.00 NOK |
2011-06-09 | Årsstämma 2011 |
2011-04-28 | Kvartalsrapport 2011-Q1 |
2011-02-17 | Bokslutskommuniké 2010 |
2010-10-21 | Kvartalsrapport 2010-Q3 |
2010-08-19 | Kvartalsrapport 2010-Q2 |
2010-06-04 | Ordinarie utdelning CONTX 0.00 NOK |
2010-06-03 | Årsstämma 2010 |
2010-04-21 | Kvartalsrapport 2010-Q1 |
2010-02-18 | Bokslutskommuniké 2009 |
2009-10-22 | Kvartalsrapport 2009-Q3 |
2009-08-20 | Kvartalsrapport 2009-Q2 |
2009-04-23 | Kvartalsrapport 2009-Q1 |
2008-06-06 | Ordinarie utdelning CONTX 1.50 NOK |
Beskrivning
Land | Sverige |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Medicinteknik |
STOCKHOLM - Feb 16, 2023 - ContextVision, a medical technology software company specializing in image processing and image analysis, today reports its fourth quarter results.
Net sales record
The company delivers another record quarter with a net sales of SEK 32.6 M, an increase of 19%. For the full year, net sales increased 20% to SEK 117.8 M (98.1). This represents the strongest fiscal quarter and full year in ContextVision's history.
In Q4, EBITDA reached SEK 11.0 M (12.3). Post pandemic higher sales and marketing cost reflecting more in-person customer events and meetings including travel and exhibitions impact Q4. The full year delivered a solid EBITDA of 41.7% (51.3%) with the current cost structure representing the effect of the spin-off from Inify Laboratories in February 2022.
The strong growth in this quarter mainly resulted from the Asian and Americas markets, with a double-digit increase in the latter. The market mix for the full year shows Asia as largest with 68% of net sales, Europe 17% and Americas 15%. The company's X-ray products continue to increase their market shares, with key updates added during the year. For the Ultrasound market, a new 3D solution was released earlier in the year together with a full mobile solution. Both solutions have attracted great interest in the market and have already resulted in signed contracts.
"We have continued on our strategic path with a clear focus on our core business, and it has clearly proven to be successful. It is now time to further accelerate and take the next step in the growth of the company," says Gerald Pötzsch, CEO of ContextVision.
Summary:
Strongest net sales for Q4 and for the fiscal year 2022. With a strong EBITDA, a solid cash position and an unmatched product portfolio, the company is ready to take its next leap.
For further information, please contact ContextVision's CEO, Gerald Pötzsch, at +46 8 750 35 50 or gerald.potzsch@contextvision.comor visit www.contextvision.com (https://www.globenewswire.com/Tracker?data=3MaQGqfStsB_Z2n6YL96mk-0dfygLw6oN4eKvMWXKupICwsDDzA5ube1toUXebPYzar4qnu3TeaXF33IVlLZ60EyMCEFEOWZap0EhVSqE-zUKei2pFNr5cBFltRYMNo6kn7oL7CJxcgVx-hYON67FOGIkP2rl4-54NJMeD5MzrIVSQFWmgmZB085ANCWw_-3WhU_QFycYwSw79n9hRO8bD7Hmgptb56Phn4abKPm1hKO_3dkThorqVpb9FHkE5KXb2U2zArc9gueaSXiPxhqyw==).
###